News
-
-
COMMUNIQUÉ DE PRESSE
Mutares increases consolidated revenues by 15% in the first half of the year and once again achieves positive Adjusted EBITDA – forecast for full year 2024 confirmed
Mutares SE & Co. KGaA reports 15% revenue growth in H1 2024 with positive Adjusted EBITDA. Expansion into China, India, and the US planned. Forecast for FY 2024 confirmed -
COMMUNIQUÉ DE PRESSE
Evotec announces strong progress in strategic protein degradation partnership with Bristol Myers Squibb
Evotec SE announces strong progress in strategic partnership with Bristol Myers Squibb for molecular glue degraders, triggering payments of US$75m. Joint pipeline expanding in oncology field -
-
COMMUNIQUÉ DE PRESSE
H1 2024 results: RENK Group AG continues successful business development with record figures – more precisely defined financial guidance at upper end of the forecast range
RENK Group AG reports record figures in H1 2024 results with revenue up 24.4% driven by defense sector. Raised financial guidance for 2024 to upper end of the forecast range -
COMMUNIQUÉ DE PRESSE
DATAGROUP with higher sales momentum in the third quarter – Full-year forecast entirely confirmed
DATAGROUP SE reports higher sales momentum in Q3 2023/2024, with 7.5% yoy revenue growth and confirmed full-year forecast. Investments in AI, cybersecurity, and cloud technologies driving organic growth -
-
-
-
COMMUNIQUÉ DE PRESSE
Solid progress in H1 2024 – Upgrade of 2024 full-year guidance – Mid-term target to double 2023 revenue by 2028
PolyPeptide Group AG reports solid progress in H1 2024 with upgraded full-year guidance and mid-term target to double 2023 revenue by 2028. Revenue growth driven by commercial activities and operational improvements
